Stockscreener 앱 받기
6.40
7.74%
0.46
전일 마감가:
$5.94
열려 있는:
$5.95
하루 거래량:
1.22M
Relative Volume:
1.53
시가총액:
$351.35M
수익:
$124.00K
순이익/손실:
$-49.99M
주가수익비율:
-3.787
EPS:
-1.69
순현금흐름:
$-31.03M
1주 성능:
+12.08%
1개월 성능:
+11.50%
6개월 성능:
-6.57%
1년 성능:
-16.78%
1일 변동 폭
$5.90
$6.51
1주일 범위
$5.53
$6.51
52주 변동 폭
$4.25
$13.68
Candel Therapeutics Inc Stock (CADL) Company Profile
명칭
Candel Therapeutics Inc
전화
617-916-5445
주소
117 KENDRICK STREET, NEEDHAM
CADL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CADL
Candel Therapeutics Inc
|
6.40 | 326.10M | 124.00K | -49.99M | -31.03M | -1.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Candel Therapeutics Inc Stock (CADL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-28 | 개시 | Stephens | Overweight |
| 2025-09-03 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-06-30 | 재개 | H.C. Wainwright | Buy |
| 2025-02-20 | 개시 | Citigroup | Buy |
| 2025-02-19 | 개시 | Canaccord Genuity | Buy |
| 2025-02-07 | 개시 | BofA Securities | Buy |
| 2022-12-02 | 개시 | H.C. Wainwright | Buy |
| 2021-11-19 | 개시 | BMO Capital Markets | Outperform |
| 2021-08-23 | 개시 | Credit Suisse | Outperform |
| 2021-08-23 | 개시 | Jefferies | Buy |
| 2021-08-23 | 개시 | UBS | Buy |
모두보기
Candel Therapeutics Inc 주식(CADL)의 최신 뉴스
Trading the Move, Not the Narrative: (CADL) Edition - Stock Traders Daily
Breakeven On The Horizon For Candel Therapeutics, Inc. (NASDAQ:CADL) - simplywall.st
Aug Highlights: Will Xometry Inc stock recover after earningsPortfolio Risk Report & Pattern Based Trade Signal System - baoquankhu1.vn
Loss-Making Candel Therapeutics, Inc. (NASDAQ:CADL) Expected To Breakeven In The Medium-Term - Yahoo Finance
Sectors Review: Will Candel Therapeutics Inc stock maintain momentum in 2025Earnings Trend Report & Consistent Profit Alerts - Bộ Nội Vụ
Is Candel Therapeutics Inc. stock affected by interest rate hikesTake Profit & Safe Entry Zone Tips - Улправда
Valuation Update: Will Candel Therapeutics Inc. stock outperform tech sector in 2025IPO Watch & Consistent Profit Trade Alerts - Улправда
Can Candel Therapeutics Inc. stock attract ESG capital inflows2025 Momentum Check & Consistent Return Strategy Ideas - Улправда
Aug Volume: Will Candel Therapeutics Inc. stock outperform tech sector in 20252025 Analyst Calls & Free Weekly Chart Analysis and Trade Guides - Улправда
Can Candel Therapeutics Inc. stock sustain free cash flow growth2025 Valuation Update & Trade Opportunity Analysis - Улправда
Will Candel Therapeutics Inc. stock outperform tech sector in 2025IPO Watch & Consistent Profit Trade Alerts - Улправда
Analysts Offer Insights on Healthcare Companies: Candel Therapeutics (CADL) and Stereotaxis (STXS) - The Globe and Mail
(CADL) Volatility Zones as Tactical Triggers - Stock Traders Daily
Candel Therapeutics, Inc. (NASDAQ:CADL) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Understanding the Setup: (CADL) and Scalable Risk - Stock Traders Daily
Candel Therapeutics, Inc.(NasdaqGM: CADL) added to NASDAQ Biotechnology Index - marketscreener.com
Can Candel Therapeutics Inc. stock surprise with earnings upside2025 Momentum Check & Risk Adjusted Buy/Sell Alerts - Улправда
Candel Therapeutics Earnings Notes - Trefis
Why Candel Therapeutics Inc. stock is rated strong buyOil Prices & Stepwise Swing Trade Plans - Улправда
Will Candel Therapeutics Inc. stock outperform Dow Jones index2025 AllTime Highs & Long-Term Capital Growth Ideas - DonanımHaber
Will Candel Therapeutics Inc. stock maintain growth storyStop Loss & AI Powered Buy and Sell Recommendations - Улправда
Bear Alert: Why Candel Therapeutics Inc. stock is rated strong buyWeekly Gains Summary & Weekly Breakout Watchlists - Улправда
How (CADL) Movements Inform Risk Allocation Models - Stock Traders Daily
B of A Securities Downgrades Candel Therapeutics (CADL) - MSN
Candel Therapeutics, Inc. $CADL is Acorn Capital Advisors LLC's 5th Largest Position - MarketBeat
Is Candel Therapeutics On The Move With Pipeline Progress And Market Momentum? - RTTNews
Diamond Hill Investment Group, Rhythm Pharmaceuticals, Vail Resorts And Other Big Stocks Moving Higher On Thursday - Benzinga
Brookline Capital Management Weighs in on CADL Q4 Earnings - MarketBeat
Citi Maintains Candel Therapeutics(CADL.US) With Buy Rating, Maintains Target Price $24 - 富途牛牛
Candel Therapeutics (NASDAQ:CADL) Shares Little Changed on Clinical-Stage Progress - Kalkine Media
Stephens Reaffirms Overweight Rating for Candel Therapeutics (NASDAQ:CADL) - MarketBeat
Candel Therapeutics, Inc. (NASDAQ:CADL) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
CADL: CAN-2409's phase 3 success and strong market outlook drive launch readiness and pipeline expansion - TradingView
CADL: CAN-2409's phase III success and strong market readiness position it for rapid adoption and growth - TradingView — Track All Markets
CADL: Late-stage immunotherapy programs advance toward commercialization and regulatory milestones - TradingView — Track All Markets
Candel Therapeutics, Inc. Hosts R&D Day Highlighting Viral Immunotherapy Advances - TradingView — Track All Markets
Candel Therapeutics, Inc. (CADL) Stock Analysis: Unveiling a 271% Potential Upside in Biotech - DirectorsTalk Interviews
How Candel Therapeutics Inc. stock trades before earningsJuly 2025 Sentiment & AI Driven Stock Price Forecasts - Newser
Is Candel Therapeutics Inc. stock recession proof2025 Price Targets & Long-Term Capital Growth Strategies - Newser
Candel Therapeutics (CADL) Stock Analysis Report | Financials & Insights - Benzinga
Is Candel Therapeutics Inc. stock attractive after correctionWeekly Volume Report & AI Forecast for Swing Trade Picks - Newser
Is Candel Therapeutics Inc. stock resilient to inflationPortfolio Update Summary & Safe Capital Investment Plans - Newser
Candel: lighting the path to a brighter future for patients with solid tumors - Nature
Candel Therapeutics (CADL) Upgraded to Strong Buy: Here's What You Should Know - MSN
Candel Therapeutics Stock Headed For 20% Weekly Gains: Retail Over The Moon With BofA's 'Buy' Call - MSN
Candel Therapeutics stock price target raised to $14 by Freedom Capital - Investing.com Nigeria
Will Candel Therapeutics Inc. stock gain from strong economy2025 Price Targets & High Accuracy Trade Alerts - newser.com
What technical models suggest about Candel Therapeutics Inc.’s comebackIndex Update & Safe Entry Zone Tips - newser.com
Why Candel Therapeutics Inc. stock could see breakout soon2025 Earnings Impact & Verified Swing Trading Watchlists - newser.com
How geopolitical tensions affect Candel Therapeutics Inc. stockPortfolio Update Report & Stepwise Trade Signal Guides - newser.com
Candel Therapeutics Inc (CADL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Candel Therapeutics Inc 주식 (CADL) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Nichols William Garrett | Chief Medical Officer |
Jul 28 '25 |
Sale |
6.98 |
937 |
6,540 |
52,493 |
| Nichols William Garrett | Chief Medical Officer |
Jun 30 '25 |
Option Exercise |
1.29 |
781 |
1,007 |
53,274 |
| Nichols William Garrett | Chief Medical Officer |
Jun 30 '25 |
Sale |
5.04 |
781 |
3,936 |
52,493 |
4.73%
0.92%
자본화:
|
볼륨(24시간):